Ferncliff Listed DAI AS has on 25 August 2023 purchased 200,000 shares in Vistin Pharma ASA at NOK 21 per share.
After the transaction Ferncliff Listed DAI AS has a holding of 1,234,280 shares, corresponding to 2,78% ownership. Ferncliff Listed DAI AS is closely associated with board member Øystein Stray Spetalen.
Attachment
PALO ALTO, Calif.--(BUSINESS WIRE)--#DiabetesData--Tidepool, a software company committed to innovations in diabetes management, is thrilled…
FORT COLLINS, CO / ACCESSWIRE / April 5, 2024 / Pathways Hospice recently named Dr.…
DUBLIN--(BUSINESS WIRE)--The "United States Clinical Oncology Next Generation Sequencing Market, By Region, By Competition Forecast…
LAS VEGAS, NV / ACCESSWIRE / April 5, 2024 / All Care Therapies, a leading…
TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero"…
TORONTO, ON / ACCESSWIRE / April 5, 2024 / Theralase® Technologies Inc. ("Theralase®" or the…